Lessons learnt during the COVID-19 pandemic: Why Australian schools should be prioritised to stay open.
Journal
Journal of paediatrics and child health
ISSN: 1440-1754
Titre abrégé: J Paediatr Child Health
Pays: Australia
ID NLM: 9005421
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
05
05
2021
received:
29
03
2021
accepted:
05
05
2021
pubmed:
9
6
2021
medline:
10
9
2021
entrez:
8
6
2021
Statut:
ppublish
Résumé
In 2020, school and early childhood educational centre (ECEC) closures affected over 1.5 billion school-aged children globally as part of the COVID-19 pandemic response. Attendance at school and access to ECEC is critical to a child's learning, well-being and health. School closures increase inequities by disproportionately affecting vulnerable children. Here, we summarise the role of children and adolescents in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission and that of schools and ECECs in community transmission and describe the Australian experience. In Australia, most SARS-CoV-2 cases in schools were solitary (77% in NSW and 67% in Victoria); of those that did progress to an outbreak, >90% involved fewer than 10 cases. Australian and global experience has demonstrated that SARS-CoV-2 is predominantly introduced into schools and ECECs during periods of heightened community transmission. Implementation of public health mitigation strategies, including effective testing, tracing and isolation of contacts, means schools and ECECs can be safe, not drivers of transmission. Schools and ECEC are essential services and so they should be prioritised to stay open for face-to-face learning. This is particularly critical as we continue to manage the next phase of the COVID-19 pandemic.
Identifiants
pubmed: 34101922
doi: 10.1111/jpc.15588
pmc: PMC8242752
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1362-1369Informations de copyright
© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Références
JAMA Pediatr. 2021 Jan 1;175(1):73-80
pubmed: 32857112
Front Pediatr. 2021 Jan 14;8:615894
pubmed: 33520898
Lancet Child Adolesc Health. 2021 Jun;5(6):417-427
pubmed: 33740430
Nature. 2020 Nov;587(7835):536-539
pubmed: 33239802
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S146-S163
pubmed: 32894747
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025
pubmed: 32759921
Clin Infect Dis. 2021 Mar 15;72(6):1055-1058
pubmed: 32584975
J Pediatr Nurs. 2020 Sep - Oct;54:A7-A9
pubmed: 32811702
Arch Dis Child. 2021 Feb;106(2):111-113
pubmed: 32747375
Euro Surveill. 2020 Sep;25(38):
pubmed: 32975186
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Cochrane Database Syst Rev. 2020 Dec 17;12:CD013812
pubmed: 33331665
N Engl J Med. 2021 Feb 18;384(7):669-671
pubmed: 33406327
Lancet Child Adolesc Health. 2021 Apr;5(4):256-264
pubmed: 33571450
Lancet Infect Dis. 2021 Mar;21(3):344-353
pubmed: 33306981
Lancet Child Adolesc Health. 2020 May;4(5):397-404
pubmed: 32272089
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
BMJ Open. 2013 Feb 26;3(2):
pubmed: 23447463
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
J Infect. 2021 Jul;83(1):e34-e36
pubmed: 33930468
Clin Infect Dis. 2020 Dec 3;71(9):2469-2479
pubmed: 32392337
Sci Rep. 2021 Feb 4;11(1):3044
pubmed: 33542262
Med (N Y). 2021 Feb 12;2(2):149-163.e4
pubmed: 33163984
Clin Infect Dis. 2021 Dec 16;73(12):2265-2275
pubmed: 33460434
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
Nat Commun. 2021 Oct 5;12(1):5820
pubmed: 34611158
N Engl J Med. 2020 Sep 3;383(10):981-985
pubmed: 32726550
J Infect. 2021 Apr;82(4):67-74
pubmed: 33639175
Pediatrics. 2021 Jan;147(1):
pubmed: 33055228
Lancet. 2020 Oct 10;396(10257):1059
pubmed: 33038955
Lancet Child Adolesc Health. 2020 Jun;4(6):421
pubmed: 32302537
J Paediatr Child Health. 2021 Apr;57(4):472-473
pubmed: 33817870
BMJ. 2021 Mar 18;372:n628
pubmed: 33737413
J Korean Med Sci. 2020 Nov 30;35(46):e414
pubmed: 33258334
Child Adolesc Ment Health. 2020 Sep;25(3):167-168
pubmed: 32654361
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1170-1172
pubmed: 32853185
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413743
Commun Dis Intell Q Rep. 2010 Dec;34 Supp:S1-167
pubmed: 21416762
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
CMAJ. 2021 Apr 26;193(17):E601-E606
pubmed: 33837039
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1319-1323
pubmed: 32941418
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Lancet Public Health. 2020 May;5(5):e243-e244
pubmed: 32275858
JAMA Pediatr. 2020 Sep 1;174(9):898-900
pubmed: 32329784
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
Arch Dis Child. 2021 Dec;106(12):1212-1217
pubmed: 33737319
Nat Commun. 2021 Feb 17;12(1):1084
pubmed: 33597531
Euro Surveill. 2020 Dec;25(49):
pubmed: 33303065
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140
pubmed: 33507890
Pediatrics. 2021 May;147(5):
pubmed: 33688033
J Infect. 2020 Dec;81(6):979-997
pubmed: 32858069